Bryostatin 1 and High Dose Cytarabine in Treating Patients With Refractory or Relapsed Leukemia or Lymphoma

This study has been completed.

Study NCT00003079 Information provided by Virginia Commonwealth University

First Received: May 2, 2000 Last Updated: February 15, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2001
Primary Completion Date:	May 2001 (Final data collection date for primary outcome measure)